2026-08-27

Conversational specialists such as Medical Image Analyst are stronger when you need systematic observational analysis across many image types from an upload, while hospital platforms such as Aidoc and Lunit remain stronger when you need FDA-cleared, worklist-embedded triage for a narrow set of acute findings. General-purpose chatbots such as ChatGPT and Gemini sit in between: they accept medical images, but they are not built as imaging workups with calibrated urgency language.
The distinction matters more in 2026 than it did a few years ago. Radiology already accounts for 76% of FDA-authorized AI/ML medical devices, and hospital tools are optimized for that cleared, single-finding workflow. Patients and clinicians, meanwhile, still show up with phone photos, dental films, dermoscopic shots, and PDFs of someone else's report.
Key factors that separate a useful AI image read from a confident-sounding guess:
✅ Modality breadth versus cleared-use-case depth — a skin photo, panoramic dental film, and chest CT are different problems ✅ Observation first, interpretation second — describe what is visible before saying what it is consistent with ✅ Safety mandate — observational education is not the same as a diagnostic device ✅ Urgency with a timeframe — routine, days-to-weeks, 24–72 hours, or immediate care ✅ Access model — consumer upload versus PACS-connected hospital deployment
To compare these tools honestly, it helps to score them on coverage, method, regulatory mandate, memory, urgency calibration, and who can actually use them today.
AI medical image analysis is now a mainstream question because imaging AI has moved from research demos into both hospital worklists and consumer chat windows at the same time. A 2025 review of FDA AI/ML authorizations found 950 devices, 723 of them in radiology, and 295 additional AI/ML devices were cleared in 2025 alone.
That hospital layer is real. Aidoc markets always-on algorithms that prioritize suspected acute findings, quantify repetitive measurements, and route results into radiologist worklists and care-team apps. Lunit, according to a 2026 platform comparison last tested in July 2026, is deployed in 5,000-plus institutions for chest X-ray and mammography screening.
The consumer layer is just as real, and much less regulated. People now photograph a lesion, screenshot a lab portal, or export an MRI series and ask a chatbot what it shows. Peer-reviewed work has already begun comparatively assessing general-purpose systems such as ChatGPT and Gemini on medical imaging-related tasks.
The clinical literature is also clearer about what AI can and cannot absorb. Reviews note that AI can speed interpretation of complex images and support earlier detection, while a July 2025 European Commission Joint Research Centre report stressed that deployment still depends on data quality, interpretability, and clinical validation. The American College of Radiology released draft Practice Parameters on AI in Radiology in 2025 covering governance, real-world performance monitoring, bias mitigation, and quality assurance.
The practical result is a split market. Hospitals buy narrow, cleared detectors. Individuals and many clinicians want a second set of trained eyes on whatever image is in front of them. Those are not the same product, even when both are labeled "AI imaging."
You should look for modality coverage, a systematic reading method, an explicit safety mandate, memory of prior images, calibrated urgency, and an access model that matches your setting. Accuracy headlines are a weak primary filter, because most public tools are not comparable on the same endpoint.
This article uses a Six-Dimension Imaging Analyst Scorecard:
Hospital platforms usually win on mandate and market access inside a health system. Aidoc's radiology suite is built around EHR, PACS, scheduling, and reporting integrations, with algorithms spanning intracranial hemorrhage, pulmonary embolism, aortic dissection, and other acute findings. That is the right design if the image never leaves the scanner network.
Conversational analysts usually win on modality coverage and access. A parent with a phone photo of a rash, a dentist reviewing a panoramic film, and a resident looking at a wound photograph are not Aidoc customers. They still need a structured read, an honest quality gate, and a next clinical pathway.
Three failure modes show up repeatedly when people use generic chatbots as imaging readers:
A strong analyst refuses to speculate on a non-diagnostic image, states laterality and orientation, separates what is seen from what it is consistent with, and says when the image cannot answer the question. Those behaviors matter more than a marketing claim of "AI diagnosis."
Jenova's Medical Image Analyst is the strongest conversational option in this set for cross-modality observational workups, while Aidoc and Lunit remain the stronger hospital tools for cleared, workflow-embedded detection, and ChatGPT and Gemini remain the most familiar general-purpose upload targets. None of them is a universal substitute for a licensed clinician.
Jenova's agent is built as a senior imaging observer across radiology, dermatology, pathology, ophthalmology, dental imaging, and clinical photography. It accepts X-ray, CT, MRI, ultrasound, PET, SPECT, dermoscopic and clinical skin photos, fundoscopy, histopathology and cytology, panoramic and periapical dental films, CBCT, endoscopy, wound photography, and screenshots of reports or lab results.
The read is structured: image overview, systematic observations, notable findings including incidentals, ranked differential considerations phrased as "consistent with," and an urgency band with a timeframe. It does not issue a formal diagnosis and does not recommend drugs, dosages, or procedures. That is a genuine limitation if you want a treatment plan, and a genuine safety feature if you want an observational second look.
It also adapts depth. Technical language is the default for clinicians; the same rigor is paired with plain-language explanations when the user is clearly a patient. Persistent history lets later images be compared with earlier findings in the same working record. Users can generate a findings summary for physician handoff.
Limitations are equally concrete. It is not an FDA-cleared medical device, does not sit inside PACS or hospital worklists, cannot run always-on background triage on a CT stream, and cannot analyze an image that is too blurry, dark, or cropped. It is supplementary analysis, not a replacement for formal evaluation.
Related Jenova agents that the same reader often needs in the same month include Dermatology Advisor for skin-focused assessment and routines, Dental Image Specialist for dental films and clinical oral photos, and Personal Medical Analyst for symptoms, labs, and longitudinal health context around the image.
ChatGPT is the default multimodal chatbot many people already have open when they want a quick take on an uploaded scan or photo. Comparative research has evaluated ChatGPT alongside other general-purpose LLMs on medical imaging-related tasks, which is evidence of real use, not evidence that it is a radiology product.
Strengths are access, familiarity, and flexible follow-up conversation. Limitations follow from the same generality: it is not a purpose-built imaging workup, it is not FDA-cleared for diagnosis, and it does not natively apply modality-specific survey frameworks or a four-level urgency clock. Pricing for medical-image use was unverified in the sources reviewed for this article.
Aidoc is a hospital radiology AI platform, not a consumer upload tool. Its own materials describe triage alerts for suspected acute findings, quantification of repetitive tasks, worklist flagging, and care-team communication through a unified widget. A 2026 competitive review credited Aidoc with 19-plus FDA-cleared use cases and deployment in more than 1,000 hospitals.
That breadth is still radiology-centric. The same review noted that Aidoc is focused on CT and X-ray radiology and does not cover pathology or dermatology. Pricing is enterprise, typically per-scan or annual subscription. Best fit is a health system that wants always-on acute-finding triage inside existing PACS and EHR workflows.
Lunit is strongest as a screening-program engine for chest X-ray and mammography. The July 2026 Mixpeek review cited 5,000-plus institutions and more than 100 peer-reviewed publications, including stand-alone reader performance data. That evidence base is a real advantage in those two modalities.
The matching limitation is scope. Lunit is focused on chest X-ray and mammography rather than a general imaging workup. It is not the tool for a dermoscopic photo, a dental CBCT, or a consumer wound image. Pricing is enterprise, typically an annual subscription per modality per facility.
Gemini is Google's general-purpose multimodal chatbot, and it occupies the same consumer-upload niche as ChatGPT. It has been included in head-to-head evaluations of general-purpose LLMs on medical imaging-related tasks. That makes it a relevant alternative, not a hospital radiology platform.
Google's separate health-AI research stack is easy to confuse with the consumer chatbot. They are not the same deployment. Gemini's strengths are multimodal conversation and availability; its limitations are the same mandate and method gaps as other general chatbots. Pricing for imaging analysis was unverified in the sources reviewed here.
| Feature / Dimension | ChatGPT | Jenova Medical Image Analyst | Aidoc | Lunit | Gemini |
|---|---|---|---|---|---|
| Modality coverage | General multimodal uploads | Radiology, derm, path, dental, ocular, wounds, reports | Radiology CT/X-ray acute findings | Chest X-ray and mammography | General multimodal uploads |
| Reading method | General conversation | Modality-specific systematic survey | Algorithmic detection + worklist triage | Screening detection with published validation | General conversation |
| FDA-cleared imaging device | No | No | Yes; broad cleared portfolio | Yes; screening algorithms | No |
| Hospital PACS/EHR integration | No | No | Deep PACS, EHR, reporting integration | Enterprise screening workflows | No |
| Urgency output | Unstructured | Routine / timely / urgent / emergent with timeframe | Worklist reprioritization for acute findings | Screening flagging | Unstructured |
| Longitudinal comparison | Chat history, product-dependent | Cross-session image and history memory | Patient context inside hospital systems | Program-level screening history | Chat history, product-dependent |
| Pricing (as of 2026) | Unverified | Free tier with limited usage; paid plans from $20/month | Enterprise; per-scan or annual subscription | Enterprise; annual per modality per facility | Unverified |
| Best for | Quick informal questions on an image you already have | Structured observational analysis across mixed image types | Hospital acute-finding triage | Population chest X-ray and mammography screening | General multimodal chat with occasional image questions |
Systematic observation changes quality by forcing the model to finish the image before it interprets the interesting part. Impressionistic AI reads start at the most salient finding; clinical-grade reads start at anatomy, quality, laterality, and the rest of the field.
That is not a style preference. Radiology training uses survey sequences for a reason. A chest radiograph workup that never looks at the apices, costophrenic angles, or the region behind the heart will miss the incidental that actually changes urgency. A skin photo workup that skips border irregularity, color variegation, or comparison with neighboring lesions is not an ABCDE assessment, even if it names melanoma.
Jenova's agent is designed around those checklists. Skin images are worked with asymmetry, border, color, size, and evolution, plus dermoscopic clues such as pigment network, globules, streaks, and vascular pattern. Musculoskeletal films are read for cortex, medulla, alignment, joint space, and soft tissue, with contralateral comparison when both sides are available. Fundoscopy is surveyed from disc margins and cup-disc ratio through vessels, macula, and periphery. Wound photos are described by size, depth, edges, base, periwound skin, drainage, and landmarks.
General-purpose chatbots can imitate that language if you prompt them hard enough. They do not default to it, and they are less consistent about refusing a non-diagnostic capture. Hospital detectors are systematic in a different way: they are extremely consistent at one finding class and silent about everything outside that class.
The non-commodity test is incidental findings. If an AI only discusses the circled nodule and never mentions the pleural edge, the quality of the read is still incomplete. Testing this behavior on mixed uploads — a marked lesion plus a second, unmarked abnormality — is more informative than asking which brand "detects cancer."
An AI tool should flag urgency by pairing visible features with a timeframe and a specialist pathway, not by naming a disease as if it had examined the patient. That boundary is the difference between observational analysis and unlicensed diagnosis.
Jenova uses four bands: routine (next convenient visit), timely (days to two weeks), urgent (24–72 hours), and emergent (immediate care). The output sounds like "this presentation warrants dermatology evaluation within two weeks," not "you have melanoma." Treatment, medication, and procedure advice are out of scope. The appropriate next clinician is in scope.
That design matches how non-cleared tools should behave. The FDA maintains a public list of AI-enabled medical devices that have met premarket requirements. Conversational analysts are not on that list by default, and they should not talk as if they were. Hospital tools such as Aidoc are on the other side of the line: they alert on suspected acute findings so radiologists can confirm and act.
Urgency without diagnosis is also more usable for patients. A disease label without a clock produces anxiety and internet searching. A clock without a specialist type produces the wrong waiting room. Combining both — timeframe plus who to see plus what to bring — is the actionable layer.
There is a matching honesty requirement when the image is weak. If lighting, focus, cropping, or missing scale make the capture non-diagnostic, the correct urgency output is "retake," not a low-confidence disease name. Tools that always produce an interpretation train users to trust noise.
JAMA Network Open research on FDA-cleared AI devices has also raised generalizability and post-market performance questions, including recalls in some device classes. Cleared does not mean infallible. Uncleared does not mean unusable. The mandate should be stated in the same sentence as the finding.
You get a useful read by uploading the highest-quality image you can, stating the clinical context in one paragraph, and asking for quality assessment before interpretation. The same discipline applies to Jenova, ChatGPT, and Gemini; hospital platforms instead require PACS routing rather than a prompt.
For Jenova's Medical Image Analyst, a typical flow is:
"I am a patient, not a clinician. This is a phone photo of a lesion on the left forearm, anterior surface, present about three weeks. I had basal cell carcinoma excised from the left cheek in 2021. Assess image quality first. If the photo is diagnostic, give systematic observations, what the features are consistent with, incidental findings, and an urgency timeframe. Do not diagnose or recommend treatment."
A clinician prompt is shorter and more technical:
"AP and lateral left knee radiographs, 58-year-old with type 2 diabetes. Survey bones, joints, and soft tissue. Flag incidentals. Compare with the prior image in this thread. Urgency band only; no treatment plan."
For ChatGPT or Gemini, use the same quality-first instruction. Do not accept a disease name as the first sentence. Ask explicitly for laterality, a full-field survey, and what the image cannot determine.
For Aidoc or Lunit, "getting started" is an institutional project: PACS routing, worklist widgets, governance, and performance monitoring under frameworks such as the ACR's AI practice parameters. A patient cannot upload a phone photo to those systems and should not try.
Two practical constraints apply on Jenova's platform. Usage on the free tier is limited; paid plans start at $20/month with 30× the free allowance, with higher tiers at $50, $100, $200, $500, and $1,000 per month. The agent cannot schedule recurring mole checks or watch a folder of images in the background. If you need monitoring, that remains a clinical follow-up task.
Imaging experts increasingly treat conversational AI as a documentation and triage aid, not as a licensed reader, and they judge it on whether it preserves observation discipline under uncertainty. The ACR's 2025 draft AI parameters put governance, validation, bias, and ongoing quality assurance at the center of safe use, which is a warning against unaudited chatbot diagnosis.
"The failure mode we see in conversational medical image analysis is not missing the obvious finding. It is skipping the rest of the image. A chest film that jumps to the marked opacity and never checks the costophrenic angles or the apices is the same error residency programs train out of humans. If an agent cannot show its survey, it is not doing radiology-shaped work, even if the prose sounds clinical."
"Urgency without diagnosis is the useful output for a tool that is not a cleared device. Telling a user 'this is pneumonia' is both outside scope and less actionable than 'this pattern warrants evaluation within 24–72 hours, and here is the specialist type and what to bring.' The clock and the pathway are the product. The disease name is often theater."
"Hospital AI and conversational analysts are not substitutes. One sits on the scanner worklist with FDA clearance and a single finding class. The other sits with the person who has a phone photo, a dental film, and last year's MRI on a USB stick. Comparing them only on ROC curves misses the access problem that actually drives 2026 usage."
— Jenova Product Team, AI imaging product design (8 years)
That view lines up with independent assessments. Nature's 2025 analysis of FDA-authorized AI devices found radiology was the lead review panel for 88.2% of imaging-based devices, which explains why commercial depth clustered in CT and X-ray triage. Clinflows' 2025 overview of AI image analysis likewise framed speed and workflow efficiency as the near-term gain, with validation and implementation as the constraint.
For ordering the next study rather than reading the current one, clinicians still have ACR Appropriateness Criteria as the evidence-based map of which exam to request. Conversational analysts can describe an image in hand. They should not silently replace appropriateness guidelines.
FDA-cleared hospital radiology AI is the better fit when the image is already inside a clinical imaging system and the job is to detect a defined acute or screening finding at scale. Conversational analysts are the better fit when the image is in a person's hands, the modality is mixed or non-radiology, or the need is a structured observational workup rather than a binary detector.
Choose Aidoc when a health system needs always-on CT and X-ray triage across many body regions, with worklist reprioritization and care-team notification. Published Aidoc use cases include intracranial hemorrhage, vessel occlusion, pulmonary embolism, aortic dissection, and a long list of abdominal acute findings. Choose Lunit when the program is chest X-ray or mammography screening with a large published evidence base. Choose Viz.ai, per the same 2026 landscape review, when stroke and neurovascular time-to-treatment is the primary workflow, not general image explanation. Choose Qure.ai when the setting is public-health screening or a lower-resource hospital that needs chest X-ray, head CT, or spine AI with edge deployment.
Choose Jenova's Medical Image Analyst when the user is a clinician wanting a systematic second look, or a patient who needs to know whether a photo or scan warrants timely evaluation and which specialist to call. It is also the more coherent option when the packet is mixed: a wound photo plus a prior report screenshot plus a question about laterality.
Choose ChatGPT or Gemini when you already live in that chatbot and the question is informal, low-stakes, and you are willing to re-prompt for structure. They are weaker when you need a quality gate, a four-level urgency band, or consistent incidental-finding discipline.
A useful rule: if missing the finding for 15 minutes could change outcome inside a hospital, you want a cleared detector on the worklist. If the problem is "what am I looking at, how worried should I be, and who should see this," you want an observational analyst with an explicit non-diagnosis mandate. In 2026, those jobs still do not live in the same product, and treating them as one category is how both patients and procurement teams buy the wrong tool.